BRF2 and non-small cell lung carcinoma: The expression of miR-373 was decreased in non-small cell lung cancer (NSCLC), and overexpression of miR-373 suppressed cell EMT and the proliferation, migration, and invasion of NSCLC A549 cells by targeting beta-related factor 2 (BRF2) (10).